Thursday, August 16, 2018
 
 
Company News: Page (1) of 1 - 08/08/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Global Ophthalmology Devices Market Expected to Grow to USD 84.16 billion by 2022: Radiant Insights, Inc.

(August 08, 2018)


"Radiant Insights,Inc"
Radiant Insights has announced the addition of “Global Ophthalmology Devices Market 2018-2022" Market Research report to their database.

About Ophthalmology Devices

An ophthalmology device is a medical device used to identify, diagnose, and treat a defect of an individual's visual pathway. These devices are mainly used for people who have ophthalmic disorders such as glaucoma, cataract, retinal disorders, dry-eyes, myopia, hypermetropia, and presbyopia. Ophthalmology devices help pre-exam, diagnose, and treat the ocular diseases.

Covered in this report

The report covers the present scenario and the growth prospects of the global ophthalmology devices market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of ophthalmology devices.

The market is divided into the following segments based on geography:

• Americas

• APAC• EMEA

Request for Free Sample at: https://www.radiantinsights.com/research/global-ophthalmology-devices-market-2018-2022/request-sample

This report, Global Ophthalmology Devices Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors


• Carl Zeiss Meditec
• Essilor
• HOYA
• Johnson & Johnson
• NIDEK
• Novartis
• TOPCON
• Valeant Pharmaceuticals International

Full Research Report On Global Ophthalmology Devices Market Analysis available at: https://www.radiantinsights.com/research/global-ophthalmology-devices-market-2018-2022

Market driver
• Increasing number of eye disorders
• For a full, detailed list, view our report

Market challenge
• High cost associated with ophthalmology devices and procedures
• For a full, detailed list, view our report

Market trend
• Increasing number of strategic M&A
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2022 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

Browse reports of similar category available with Radiant Insights, Inc.:
• Global Mouthwash Market:- https://www.radiantinsights.com/research/global-mouthwash-market-outlook-2018-2023
• Small Molecule Targeted Cancer Therapy Market:- https://www.radiantinsights.com/research/global-small-molecule-targeted-cancer-therapy-market-size-status-and-forecast-2018-2025

Media Contact
Company Name: Radiant Insights, Inc.
Contact Person: Michelle Thoras, Corporate Sales Specialist - USA
Email: [email protected]
Phone: (415) 349-0054, Toll Free: 1-888-928-9744
Address:201 Spear Street 1100, Suite 3036
City: San Francisco
State: California
Country: United States
Website: www.radiantinsights.com/research/global-ophthalmology-devices-market-2018-2022



Source: www.abnewswire.com


Page: 1


Related Keywords:Business,Health & Medicine,News & Current Affairs,Services,World,
Related Sites: DMN Newswire ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Neurovascular Devices Market High Revenue at USD 24,650 mn by 2023 | Therapeutic Application Hemorrhagic & Ischemic Strokes | Worldwide Segmentation by MRFR
  • Wearable Medical Devices Global Market Opportunities And Strategies To 2022
  • New Report Identifies Unique Challenges for LGBT Community Facing Alzheimer's and Other Dementias
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease,
  • The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease

    Cancer
  • Biotest AG: Cytotect(R) CP prevents transmission of Cytomegalovirus (CMV) to the unborn baby in pregnant women who are infected with CMV for the first time
  • Agenus Receives Second Milestone Payment from Merck
  • Colorado Pain Care Broadens Practice to Include Cancer Patient Treatment in Denver, CO and Surrounding Area
  • Citius Pharmaceuticals Successfully Raises $10 Million
  • ViewRay Announces Pricing of Public Offering of Common Stock
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines